Evidence map›Paper›PMID 40878769›Full record

ArticleNanomedicine (London, England)2025

Development and functional characterization of a tissue-engineered blood-air barrier model for

Neval Sevinc Ozdemir, Simal Yaren Sahin, Halime Kenar, Vasif Hasirci

Abstract read
In one paragraph

Article in Nanomedicine (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Neval Sevinc OzdemirACU Biomaterials Center, Acibadem Mehmet Ali Aydinlar University (ACU), Istanbul, Turkiye.
Simal Yaren SahinACU Biomaterials Center, Acibadem Mehmet Ali Aydinlar University (ACU), Istanbul, Turkiye.
Halime KenarACU Biomaterials Center, Acibadem Mehmet Ali Aydinlar University (ACU), Istanbul, Turkiye.
Vasif HasirciACU Biomaterials Center, Acibadem Mehmet Ali Aydinlar University (ACU), Istanbul, Turkiye.ORCID 0000-0002-3698-8861

Funding

Scientific and Technological Research Council of Türkiye
6 · The paper itself

Abstract

backgroundThe blood-air barrier (BAB) of the lung is a critical interface responsible for gas exchange and protection against external attempts, and acts as a selective barrier. Developing in vitro models that replicate its structural and functional properties is essential in studying pulmonary diseases and their therapy.

methodsIn this study, a model consisting of alveolar epithelial (A549) and primary endothelial (pHUVEC) cells seeded on opposite sides of a thin (11 ± 4 μm), electrospun poly(ε-caprolactone) mesh of nanofibers (140-800 nm) to represent the basal membrane, and the interstitial matrix of the native BAB when coated with collagen type I, fibronectin, and laminin 511 proteins. The dense, nanofibrous architecture of the mesh enabled the formation of cellular monolayers on opposite sides, allowing gas and nutrient exchange for 14 days at air-liquid interface.

resultsThe mesh had a Young's modulus of 8.0 ± 0.8 MPa, and upon coating with proteins, the water contact angles were decreased from 127.5°±2.6 to 94.4°±3.6. Epithelial and endothelial monolayers demonstrated tight junction formation as shown by ZO-1 and CD31 expression. TEER was measured as 44 ± 5.0 Ω·cm

conclusionThis study presents a physiologically relevant in vitro BAB model for respiratory research and therapies.

Indexed as

Blood-Air BarrierTissue EngineeringCell LineEndothelial CellsEpithelial CellsHumansNanofibersPolyestersTissue ScaffoldspolycaprolactonePolyesters3D culturealveolar-capillary barrierBlood-air barrierelectrospinningin vitro lung model

Identifiers

PMID40878769
PMCPMC12517467

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.